Model N Acquires Kalderos to Expand 340B Capabilities and Gross-to-Net Analytics
June 17, 2026What You Should Know End-to-end life sciences revenue management pioneer Model N has announced its strategic acquisition of drug discount analytics platform Kalderos. The transaction consolidates Kalderos’ proprietary Truzo platform into Model N’s commercial infrastructure to provide real-time, claims-level visibility into complex 340B discount networks. Life sciences manufacturers face intensifying gross-to-net (GTN) pressures, driven by ongoing Medicare…